Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
The next leap for AI scribes provides eyes in the clinic
The introduction of vision-enabled artificial intelligence (AI) to medical scribes – the recording devices used…
Plant cell structure could hold key to cancer therapies and improved crops
Can the bend of a banana give us insight into cancer? What does the shape…
NSW: Statewide digital program embeds patient-reported outcomes into routine cancer care
A statewide initiative in New South Wales has described how structured change-management strategies can support…
S3E3 The Oncology Journal Club: To INFINITY and Beyond!
Welcome to Episode 3 of the third series of The Oncology Journal Club. Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to digest the latest oncology papers.
Bowel cancer rates are declining in people over 50. But why are they going up in younger adults?
Suzanne Mahady, Monash University Bowel cancer is the fourth most common cancer in Australia, with more than 15,000 cases diagnosed…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.